For over 25 years, the cytokine known as macrophage migration inhibitory factor (MIF) has been considered to be a product of activated T lymphocytes. We recently identified the murine homolog of human MIF as a protein secreted by the pituitary in response to endotoxin administration. In the course of these studies, we also detected MIF in acute sera obtained from endotoxin-treated, T cdl-defident (nude), and hypophysectomized mice, suggesting that still more cell types produce MIE Here, we report that ceils of the monocyte/macrophage lineage are an important source of MIF in vitro and in vivo. We observed high levels of both preformed MIF protein and MIF mRNA in resting, nonstimulated cells. In the murine macrophage cell line RAW 264.7, MIF secretion was induced by as little as 10 pg/ml of lipopolysaccharide (LPS), peaked at 1 ng/ml, and was undetectable at LPS concentrations >1/~g/ml. A similar stimulation profile was observed in LPS-treated peritoneal macrophages; however, higher LPS concentrations were necessary to induce peak MIF production unless cells had been preincubated with interferon 3, (IFN-'y). In RAW 264.7 macrophages, MIF secretion also was induced by tumor necrosis factor oe (TNF-c 0 and IFN-% but not by interleukins 1 B or 6. Of note, MIF-stimulated macrophages were observed to secrete bioactive TNF-cz. Although previously overlooked, the macrophage is both an important source and an important target of MIF in vivo. The activation of both central (pituitary) and peripheral (macrophage) sources of MIF production by inflammatory stimuli provides further evidence for the critical role of this cytokine in the systemic response to tissue invasion. N 'umerous observations over the years indicate that the hypothalamic-pituitary-adrenal axis is essential in the normal host response to infection and tissue invasion (1-4). In the course of investigating the role of the pituitary in systemic inflammatory responses, we identified the murine homolog of human macrophage migration inhibitory factor (MIF) 1 as a protein secreted by the anterior pituitary in response to LPS stimulation (5). Pituitary MIF was found to contribute to the MIF present in plasma in the postacute phase (>2 h) of endotoxemia. Recombinant murine MIF markedly increased lethality when coinjected with LPS, and anti-MIF antibody conferred full protection against lethal endotoxemia, suggesting that MIF is an important and possibly critical mediator of endotoxic shock.
N
'umerous observations over the years indicate that the hypothalamic-pituitary-adrenal axis is essential in the normal host response to infection and tissue invasion (1) (2) (3) (4) . In the course of investigating the role of the pituitary in systemic inflammatory responses, we identified the murine homolog of human macrophage migration inhibitory factor (MIF) 1 as a protein secreted by the anterior pituitary in response to LPS stimulation (5) . Pituitary MIF was found to contribute to the MIF present in plasma in the postacute phase (>2 h) of endotoxemia. Recombinant murine MIF markedly increased lethality when coinjected with LPS, and anti-MIF antibody conferred full protection against lethal endotoxemia, suggesting that MIF is an important and possibly critical mediator of endotoxic shock.
Historically, MIF has been considered a product of activated T lymphocytes and appears to exhibit a number of 1 Abbreviations used in this ~per: FBS, fetal bovine serum; MIF, macrophage migration inhibitory factor. macrophage-activating properties (6) (7) (8) (9) (10) (11) (12) . While studying MIF production in experimental endotoxemia, however, we detected MIF in acute sera obtained from LPS-injected, T celldeficient (nude), and hypophysectomized mice, suggesting that yet additional cell types may produce MIF in vivo. Since the macrophage is a major source of the cytokines that appear in response to LPS administration (13), we examined the possibility that MIF also is produced by cells of the monocyte/macrophage lineage.
In this study, we report that monocytes/macrophages synthesize and release MIF after stimulation with LPS, TNF-o~, and IFN-q/. In contrast to previously studied macrophagederived cytoldnes, both MIF protein and mRNA are present in substantial, preformed amounts in these cells. Moreover, stimulation ofmacrophages with recombinant MIF induced the secretion of significant amounts of TNF-cz, suggesting that these two cytokines may act together in a proinflammatory loop. Although previously overlooked, we conclude that the macrophage is not only a cellular target of T cell or pituitary MIF but also is an important source of MIF production in vivo.
CT). C-entamicin was from GIBCO BILL (Gaithersburg, ME)).
Thioglycollate broth (Difco, Detroit, MI) was prepared according to the manufacturer's recommendation, autoclaved, and stored protected from light at room temperature. Horseradish peroxidase-conjugated goat anti-rabbit antibody was purchased from Pierce (Rockford, IL) and 4-chloro-l-naphthol and stabilized 3,Y,5,5'-tetramethylbenzidene (TMB) substrate for horseradish peroxidase were from Promega Corp. (Madison, WI). Polyclonal anti-MIF serum was generated by immunizing New Zealand White rabbits (Hare Marland, Hewitt, NJ) with purified recombinant murine MIF (rMIF). At weeks I and 2, rabbits were inoculated intradermally with 100 ~g of rMIF diluted in CFA, and with 50/~g of rMIF diluted in IFA on week 4. Immune serum was collected 1 wk after the last inoculation.
Cytokines. rMIF was expressed in E. coil BL21/DE3 (Novagen, Madison, WI) (5) and purified to homogeneity by anion exchange (Mono Q; Pharmacia, Piscataway, NJ) and reverse phase chromatography (CS-SepPak; Millipore Corp., Milford, MA), lyophilized, and reconstituted in sodium phosphate buffer (20 mM, pH 7.2) following procedures to be reported dsewhere (Bernhagen, J., R. A. Mitchell, T. Cahndra, W. Voelter, A. Cenmi, and R. Bucala, manuscript submitted for publication). MIF bioactivity was established by measuring dose-dependent, MIF-induced augmentation of Leishmania major killing by macrophages and by neutralization of this activity with anti-MIF antibody (Gessner, A., Personal communication), rMIF contained 9 pg of endotoxin per microgram of protein as determined by the chromogenic Limulus amoebocyte assay (BioWhittaker, Inc., Walkersville, MD). Recombinant mufine TNF-cx was a generous gift from Dr. Michael Paladino (Genentech, San Francisco, CA). Recombinant marine Ibl/3 and lI~ (5 /xg/ml after reconstitution) were obtained from R&D Systems, Inc. (Minneapolis, MN) and recombinant routine IFN-~/(10 s IU/ml) was from Boehringer Mannheim (Indianapolis, IN). Cytokines were reconstituted in pyrogen-free water containing 0.1% of very low endotuxin BSA (Miles, Inc., Kankakee, IL) and stored at -80~ The endotoxin content of the reconstituted cytokines was 0.5 ng/#g of TNF-c~, 2 ng//~g of ID1B, 1.1 ng//~g of II.-6, and 0.6 pg/U of IFN-~/as determined by the chromogenic Limulus amoebocyte assay.
Animals and Experimental Design. 8-10-wk-old (19-21 g) female BALB/c (control), T cell-defident BALB/c "u/"u (nude), and hypophysectomized BALB/c mice were purchased from Charles River Labs. (Kingston, NY). Animals were housed in groups of 5 or 10 mice Per cage with free access to food and water (supplemented with 5% glucose for hypophysectomized mice) and were acclimatized for 5 d before experimentation. Mice were injected intraperitoneally with nonlethal doses of LPS (2.25 mg/kg for BALB/c and T cell-deficient mice and 50/~g/kg for hypophysectomized mice), and killed 2, 8, and 20 h after LPS challenge to collect serum. The LPS dose was adjusted to provide comparable lethality in the control BALB/c group as among the hypophysectomized mice, which are hypersensitive to endotoxin (4). 5 #1 of serum was analyzed by Western blotting and visualized with anti-MIF antibody as described below.
Organ Distribution of Murine MIF Protein. The organ distribution of MIF protein was examined in a 8-10-wk-old female BALB/c mouse killed by CO2 asphyxiation and necropsied under aseptic conditions. Organs (brain, liver, spleen, ldchaeTs, adrenals, and lungs) were excised, sectioned, and homogenized at 4~ with Tris-b~ saline (50 mM Tris-Base, 150 mM NaCl, pH 7.5) containing 1% NP-40, 0.5% denxycholic add, 0.1% SDS, 2 mM EDTA, and I mM PMSE Cellular debris was pelleted and aliquots of organ lysate supernatants, adjusted for protein concentration, were diluted with an equal volume of redudng SDS-PAGE sample buffer. Samples (equivalent to 60/~g of protein) were electrophoresed through 18% polyacrylamide gels and transferred to nitrocellulose membranes for Western blot analysis using polyclonal anti-MIF serum.
Cells. RAW 264.7 routine macrophages, THP-1 human monocytes, ASI.-1 routine and Jurkat human T lymphocyte cell lines were obtained from the American Type Culture Collection (Kockville, MD). Cells were grown in RPM11640 medium (Gibco BILL) containing 2 mM glutamine, 10% heat-inactivated fetal bovine serum (FBS) (HyClone Labs., Logan, UT), and 50/~g/ml of carbenicillin and gentamicin. Medium for ASD1 cells was supplemented with 1 mM sodium pyruvate. Thioglycollate-elicited peritoneal macrophages were obtained from BALB/c mice that were injected intraperitoneally 3-4 d previously with 2 ml of sterile thioglycollate broth. Cells were harvested under strict aseptic conditions by lavage of the peritoneal cavity with 5 ml of an ice-chilled 11.6% sucrose solution. After centrifugation for 10 min at 800 g, cells were resuspended in KPMI/10% FBS, enumerated, and plated at a density of 2 x 106 or 4 x 106 cells/well. Human PMN were isolated from peripheral blood by density gradient centrifugation as previously described (14, 15) .
MIF Content of Macrophage and T Lymphocyte Lysates.
Aliquots of 106 cells of each type were lysed with Tris-buffered saline containing 1% NP-40, 0.5% denxycholic add, 0.1% SDS and 2 mM EDTA. Cellular debris was Pelleted and the supematants were diluted with an equal volume of reducing SDS-PAGE sample buffer. 10 /~1 of lysate (equivalent to 5 • l& ceUs) was electrophoresed through 18% polyacrylamide gds and transferred to nitrocelhlose membranes for Western blot analysis using polyclonal rabbit anti-MIF serum.
Stimulation of Macrophages by LPS and Cytokines. RAW 264.7
macrophages were washed with fresh medium, harvested by gentle scraping, resuspended in R.PMI/10% FBS, and incubated at 2 x 106 or 4 x 10 ~ cells/well in 3.5-cm tissue culture phtes (Linbro| Flow Laboratories, McLean, VA). After 3 h of incubation at 37"C in a humidified atmosphere with 5% COz, nonadherent cells were removed and wells were washed twice with R.PMI/1% FBS. Ceils then were incubated for 12 h with LPS (at concentrations ranging from 1 pg/ml to 10 #g/ml) or with cytokines (1 or 10 ng/ml for TNF-a, IblB, and IL-6, and 10, 100, or 1,000 IU/ml for IFN-'y) diluted in R.PMI/1% FBS. For time course experiments, conditioned media of parallel cultures were removed at 3-, 6-, 9-, 12-, and 15-h intervals after LPS stimulation. Thioglycolhte-elicited peritoneal macrophages (107 cells/weU) were harvested as described and conditioned similarly to RAW 264.7 cells. Cells were incubated for 12 h with either LPS or IFN-3r plus LPS. When costimulated with IFN-'/and LPS, ceUs were first incubated for 1 h with IFN-3, (100 IU/ml) before addition of LPS at the indicated concentrations. At the end of each experiment, cell culture media were collected, centrifuged for 10 min at 800 g, and supplemented with PMSF (1 raM). Supernatants then were concentrated 10-fold by membrane filtration (10kD cut-ofi~ (Centricon-10; Amicon, Beverly, MA). Cellular KNA was extracted from adherent cells as described below.
RNA Extraction and lsolation of MIF mRNA by Reverse Transcription and Polymerase Chain Reaction (RT-PCR).
Total cellular RNA was extracted from macrophages with RNAzoI-B (Tel-Test Inc., Friendswood, TX) following the manufacturer's protocol. 1 ~tg of RNA was reversed transcribed using oligo (dT)~,ls and M-MLV reverse transcriptase (GIBCO BRL) in a 50 ~tl reaction. 5/zl of cDNA was amplified by PCR in a thermal cycler (model 9600; PerkinEhner/Cetus, Norwalk, CT) (denaturation for 1 rain at 94~ annealing for I min at 55~ and elongation for I rain at 72~ using mutine M1F primers 0 2 cycles), TNF primers (22 cycles), or fl-actin primers (25 cycles). Murine intron-spanning MIF and B-actin primers have been reported dsewhere (5). Intron-spanning TNF primers were 5'-GCGGAGTCC~AGG'ICTA-Y and 3'-GGC-GGC~TGGCTCTGTGAGG-5'. DNA amplification products were analyzed on 2% agarose gels and gel loading was normalized to B-actin PCR products. Quantification of MIF mRNA from LPSstimulated RAW 264.7 macrophages was done by competitive PCR as described (5, 16). The 273-bp competitive cDNA template was added at the indicated concentrations and coamplified with MIF cDNA using MIF primers.
Western Blots. For Western blotting, samples were resolved on 18% SDS polyacrylamide gels under reducing conditions and transferred onto nitrocellulose membrane (Schleicher & Schuell, Inc., Keene, NH) at 50 V and 150 mA for 16 h. Membranes were blocked with 500 mM NaCI, 50 raM Tris-Base, pH 7.5, buffer containing 5% nonfat dry milk and 0.05% Tween-20 and incubated first with polyclonal rabbit anti-rMIF serum and then with horseradish peroxidase--conjugated goat anti-rabbit IgG antibody (each diluted 1:1,000 in 500 mM NaCI, 50 mM Tris-Base, pH 7.5 buffer with 1% BSA and 0.05% Tween-20). Polyclonal rabbit anti-murine MIF serum was demonstrated to react with both natural and recombinant murine and human MIF. Incubations were for 1 h each. MIF was visualized by development with chloronaphthol/H202 or with TMB substrate, Serum MIF bands were quantified by laser densitometry (model CS-90~U; Shimadzu Corp., Braintree, MA) (17) . Faint densitometric signals in the MIF region were detected in most sera before LPS administration (0 h). Hence, scanning integrals are presented as relative serum MII: content (i.e., fold increase) normalized to the respective 0 h zone (i~., background or baseline stalnir~g) on each membrane. Each plotted point is the mean _+ SEM of individual sera from two to five animals. To further quantify the amount of circulating MIF after LPS administration in vivo, serum MIF bands were compared and quantitated relative to rMIF standards electrophoresed on the same SDS gels. Calculated estimates of serum MIP concentrations were expressed as molar concentrations.
MltZinduced Secretion of TNF by RAW 264.7 Macrophagex Cells (4 x 106/well) were processed as described above and stimulated for 12 h with rMIF at specified concentrations ranging from 100 pg/ml to 1/zg/ml. At 1/zg/ml of rMIF, LPS contamination was 9 pg/ml as assessed by Liraulus assay. To neutralize this minute amount ofLPS, rMIF was preincubated for 1 h at 37~ with polymyxin B (1/~g/ral). MIl~-induced TNF activity in cell culture suPernatant was quantitated by L929 cell cytotoxicity as described previously (18) . MIF-induced TNF activity was blocked completely by anti-TNF antibodies, rMIF did not contribute to TNF activity, as recombinant routine TNF (dose range, 5 pg/ml-1/zg/ml) cytotoxicity remained unchanged when rMIF (10 pg/ml-10/zg/ml) or anti-MIF polyclonal serum was added to L929 cells together with rTNF.
Results

Serum MIF Levels in LPS-injected Mice.
We recently reported that pituitary MIF contributes significantly to the 1897 Calandra et al.
MIF that appears in serum during endotoxemia. Serum MIF reached peak levels in normal mice at 20 h but was undetectable in hypophysectomized mice at this time, suggesting that the pituitary is a major source of the MIF that appears in serum after LPS injection (5) .
The central role played by MIF in endotoxic shock, together with the known h~s i t i v i t y of hypophysectomized mice to LPS, led us to examine more dosdy the kinetics of MIF appearance in the circulation during the early, acute phase (i.e., 2-8 h) of endotoxemic shock. For purposes of comparison, we also examined serum MIF kinetics in nude mice, which lack a T cell source of MIE Control, hypophysectomized, and nude mice were injected with LPS and serum prepared at intervals and quantified for MIF content by Western blotting and laser scanning densitometry (Fig. 1) . Whereas serum MIF concentrations increased gradually over 20 h in control mice, hypophysectomizeed mice exhibited a rapid rise and then prompt fall in MIP that peaked 2 h after LPS injection. In nude mice, the rise in serum MIP was delayed by 8-12 h, but increased in a manner that was similar to that of the control mice. Peak serum MIF concentrations were compared and quantitated relative to rMIF standards electrophoresed and transferred on the same nitrocellulose membrane. Estimates of peak serum MIF in the different experimental groups were calculated to be in the range of 30-60 riM.
Given the lack of a pituitary source of MIF in the hypophysectomized mice, we considered that the MIF present in the circulation at 2 h must reflect the release of MIF by an additional LPS-sensitive cell population. Such serum MIF kinetics were reminiscent of a macrophage TNF response (19-21) and we next examined the possibility that MIF is produced by cells of the monocyte/macrophage lineage. 
Expression of MIF in Resting Macrophages and Mouse Tis-
sues. Since both a pituitary cell line (AtT-20) and the whole pituitary in vivo contain substantial amounts of preformed MIF (5), we first analyzed the intracellular MIF content of various inflammatory cells and cell lines. Significant amounts of preformed MIF protein were found to be present in cell lysates obtained from resting, nonstimulated murine RAW 264.7 cells, murine peritoneal macrophageg and human THP-1 monocytes (Fig. 2 A) . We estimate that on average there is 0.1-1 pg of immunoreactive, preformed MIF protein per macrophage. The MIF content of murine or human monocytes/macrophages was similar to that of two T cell lines, the human Jurkat and the marine ASL-1. In contrast, cell lysates obtained from purified PMN exhibited no detectable MIF protein (Fig. 2 A) .
We then examined the organ distribution of MIF protein in normal mice. Mouse tissues were homogenized and aliquots of total protein dectrophoresed and analyzed by Western blotting. As shown in Fig. 2 B, preformed MIF was detectable in mouse liver, spleen, kidney, and brain. These organs con~n significant amounts of macrophages, suggesting that the MIF protein present in these tissues is at least partly macrophage associated.
MIF Secretion by LPS-stiraulated Macrophages. MIF was ob-
served to be secreted by macrophages into culture medium after LPS stimulation (Fig. 3) . In RAW 264.7 macrophages, MIF secretion was induced by as little as 10 pg/ml of LPS, peaked at 1 ng/ml, and was not detectable at LPS concentrations >1/~g/ml (Fig. 3 A) . In elicited peritoneal macrophages, 1 ng/ml of LPS was required to induce MIF secretion, and a maximal response was observed with 10-100 ng/ml of LPS (Fig. 3 B) . Of significance, costimulation of cells with IFN-'y (100 IU/ml, given 1 h before LPS) plus LPS resulted in a >1,000-fold increase in LPS responsiveness (Fig. 3 C) .
We next examined the time course of MIF secretion in parallel cultures of RAW 264.7 macrophages maximally stimulated with 1 ng/ml of LPS. As assessed by Western blotting, MIF was first detected 6-9 h after LPS stimulation. Maximum amounts of MIF appeared in medium between 9 and 12 h after LPS stimulation (Fig. 4) . MIF levels then decreased, indicating that after 12 h, MIF is degraded at a rate that exceeds that of synthesis and release by macrophages.
Expression of MlF mRNA by LPS-stirnulged Macrop~gez
The expression of MIF mRNA by LPS-stimulated RAW 264.7 macrophages was investigated by RT-PCR. Parallel cultures were incubated for 12 h with medium or increasing amounts of LPS and analyzed for the expression of MIF, TNF-a, and /3-actin. MIF mRNA was expressed constitutively in nonstimulated murine RAW 264.7 ( Fig. 5 ) and in didted peritoneal macrophages (data not shown). As expected, the expression of TNF-oe increased over the range of LPS concentrations (1 pg/ml-1 #g/m1). In contrast, MIF mKNA levels correlated inversely with LPS concentration. MIF mRNA level was highest in calls induced with 1 pg/ml of LPS and lowest in those induced by 1 #g/ml of LPS.
To assess more quantitatively the induction ofMIF mKNA, cDNA was prepared from control and LPS-stimulated cultures of RAW 264.7 macrophages and analyzed by competitive PCR. The amount of competitive template that was required to obtain equivalent levels of MIF and competitor DNA amplification products was 1.5 pg for nonstimulated (control) macrophages and 3 pg for LPS-induced (100 pg/ml) RAW 264.7 macrophages (Fig. 6) . Therefore, macrophage MIF mRNA increased approximately twofold after LPS induction, a level comparable to that observed in pituitary cells in vivo (threefold after induction with 45 #g of LPS injected intraperitoneally) (5). We next examined the time course of MIF mRNA in RAW 264.7 macrophages incubated with 1 ng/ml of LPS, the LPS concentration that induced max- Figure 5 . RT-PCR analysis of MIP, TNF-a, and/3-actin expression by LPS-stimuhted RAW 264.7 macrophages. Cells (4 x 106) were incubated for 12 h in medium containing KPMI/1% FBS and LPS at the indicated concentrations. Total cellular KNA was extracted, cDNA prepared, and gene-specific PCR products analyzed by agarose gel dectrophoresis as described in Materials and Methods.
imum MIF secretion in these cells (see Fig. 3 ). MIF mRNA levels increased 6 h after LPS induction and remained devated for up to 12 h after LPS induction (data not shown).
Interaction between MIF and Proinflammatory Cytokines. The detection of elevated levels of MIF in blood after LPS administration ( Fig. 1) together with the finding of an important role for MIF in experimental endotoxemia (5) led us to investigate the interaction between MIF and other proinflammatory cytokines. We first studied MIF secretion by RAW 264.7 macrophages stimulated with recombinant murine TNF-c~, IL-1/$, IL-6, or IFN-% By Western blotting, TNF-ot and IFN-T were found to induce MIF secretion in a dosedependent fashion (Fig. 7) . The lowest concentration of cytokine that was effective under these experimental conditions was 1 ng/ml of TNF-c~ and 10 IU/ml of IFN-% The TNF-o~ and IFN-7 effects could not be accounted for by LPS contamination of recombinant cytokine preparations, which were found to be 0.5 pg/ng of TNF-o~ and 60 fg/U of IFN~. LPS and 1FN~y had an additive/synergistic effect on MIF secretion, whereas TNF-a and IL-1/3 did not (data not shown). Finally, MIF production was not induced by either IL-1/3 or IL-6 at 1 or 10 ng/ml.
We then examined the secretion of TNF-c~ and IL-1/3 by RAW 264.7 macrophages stimulated with rMIF. MIF samples were preincubated for 1 h with polymyxin B at 1 #g/ml to neutralize small amounts of contaminating LPS (9 pg//zg of MIF by the chromogenic Limulus assay), rMIF at concentrations ~100 ng/ml was found to induce the secretion of bioactive TNF-a as determined by the L929 cytotoxidty assay (Fig. 8) . The MIF-induced TNF bioactivity was blocked completely by anti-TNF antibodies and rMIF did not contribute to TNF cytotoxicity, as recombinant murine TNF cytotoxicity was unchanged when rMIF or anti-MIF polydonal serum was ~dc~l to L929 cells together with ffNF (data not shown). IL-1/3 secretion, in contrast, was not detectable by Western blotting over the concentration of rMIF tested.
MIF was described originally as a T lymphocyte-associated activity that inhibited the random migration of guinea pig peritoneal macrophages (6, 7) . Over the years, MIF activity was reported to be associated with delayed-type hypersensitivity (6, 7), to be produced by lectin-activated T cells, and to enhance macrophage adherence, phagocytosis (8, 9) , and tumoriddal activity (10) . Nevertheless, the biological activi- ties attributed to MIF remained ambiguous, as these studies were performed with lymphocyte culture supernatants which were shown subsequently to contain other cytokines with MIF activity, such as IFN-'y and IL-4 (22) (23) (24) . More recent experiments conducted with rMIF suggest that MIF in fact activates monocytes/macrophage to kill Leishmania donovani (Gessner, A., personal communication) and tumor cells (12) . We recently isolated and cloned the routine homolog of human MIF after identifying its release by the pituitary in response to LPS administration. Pituitary MIF was found to contribute to circulating MIF levels after endotoxemia and exogenous MIF increased markedly the lethality of experimental endotoxemia in mice (5) . In this study, we sought to identify additional cellular sources of MIF. MIF was detected in the blood of LPS-challenged, T cell-deficient, and hypophysectomized mice suggesting that, in addition to the T cell and the pituicyte, other cell types contribute to MIF production in vivo. The extremely rapid rise in serum MIF which occurred in hypophysectomized mice further suggested to us a response that could be attributed to an LPS-sensitive immune cell such as the monocyte/macrophage.
Although previously unsuspected, we found that macrophages are an important source of MIF production in vivo. Resting, nonstimulated RAW 264.7 macrophages and thioglycollate-dicited peritoneal macrophages contain abundant quantities of preformed MIF. MIF protein was detected in normal mouse fiver, spleen, kidney, and brain. Much lower amounts of MIF also were found in the adrenals and lungs. These data are consistent with recent studies reporting the presence of MIF mRNA in various tumor cells and tissues (25, 26) . We detected MIF protein in macrophage-rich organs such as liver, spleen, brain, or kidney, suggesting that the MIF present in various tissues may be at least partly macrophage associated.
Various proinflammatory stimuli, such as LPS, TNF-ol, and IFN-~/were observed to be potent inducers of macrophage MIF secretion. Secretion of significant amounts of MIF occurred at rehtively low LPS concentrations (10-100 pg/ml), suggesting that macrophage-derived MIF is likely to be released in patients with gram-negative bacterial infections (27) (28) (29) . Surprisingly, MIF secretion by RAW 264.7 macrophages, and to a lesser extent by peritoneal macrophages, decreased at high concentration of LPS (1-10/~g/ml). Analysis of the expression of MIF mB.NA yielded similar results, as MIF mRNA levels decreased markedly with increasing LPS concentrations (>0.1 ng/ml of LPS). This contrasts with the macrophage TNF response where expression of both TNF protein and mlLNA increased in a dose-dependent fashion. Possible mechanisms for the apparent downregulation of MIF at high LPS concentration are not immediately evident. Neverthdess, the relatively low leeds of LPS which initiate this dowuregulation suggests that a similar downregulatory response is likely to occur in vivo as well.
The net concentration of MIF in supernatants of macrophage cultures peaked about 12 h after LPS stimulation. In vivo, however, elevated serum levels of MIF were detected as early as 2 h after LPS administration and increased in a time-dependent manner. MIF levels were nearly maximal 8 h after LPS administration and plateaued thereafter. In hypophysectomized mice, serum MIF levels peaked 2 h after LPS injection. The mechanism responsible for this rapid rise in serum MIF is unknown, but may be related to the welldescribed hypersensitivity of hypophysectomized animals to LPS (4) . In contrast, the appearance of serum MIF was delayed in T cell-defident mice, suggesting that T cells either contribute directly to the early rise of serum MIF, or act indirectly by releasing cytokines such as TNF-oe or IFN-'I/that then promote the release of macrophage MIF.
Indeed, TNF-c~ and IFN-7 but not IL-1/~ and IL-6 were found to be potent inducers of MIF secretion by macrophages in vitro. Of importance, rMIF also was found to induce TNF secretion by macrophages, suggesting that MIF and TNF may act together to augment acute, proinflammatory responses. In the situation of a severe infection however, the proinflammatory effects of MIF may be detrimental as indicated by our recent findings that MIF markedly increased lethality when coinjected with LPS, whereas anti-MIF antibody prevented LPS lethality. These data also suggest that in extreme situations such as septic shock, MIF, like TNF, may be overproduced, and neutralization of either cytokine can be shown to fully protect against the toxicity of endotoxin administration (5, 30--33) .
The production of MIF by LPS-stimulated macrophages indicates that this cytokine may serve an important role in acute inflammatory responses. Taken together with the finding that MIF is a major protein constituent of the pituitary that is released during endotoxemia, this study supports the concept that MIF plays a systemic, regulatory function in host immunity. Macrophage MIF, once released by a proinflammatory stimulus, may act in concert with TNF-ot and other cytokines to coordinate host defenses against infection or tissue invasion. Pituitary MIF, on the other hand, may serve to prime systemic immune responses once a localized inflammatory site fails to contain an invasive agent, or rise act as a central nervous system--derived stress signal to activate the immune system in anticipation of an impending, invasive stimulus. Studies are in progress to delineate the role of pituitary, macrophage, and T cell MIF in acute and chronic inflammatory conditions.
We are grateful to Drs. A. Cerami for invaluable discussions and support during these studies. ]3. Sherry for assistance in the preparation of the PMNs, and to K. Manogue for reviewing the manuscript. 
